Tag Archives: Novartis
Health Care to 2035, Part II
How will health care evolve from where it is today to where it might be in 25 years? That’s the subject of this blog. Continue reading
Posted in Articles
Tagged 5-FU, baby boomers, colorectal cancer, demographics, doctors, financing health care, Fluorouracil, Genetech, genetic programming, genetics, Genetics*Squared, Gleevec, health, health care, health care future, health care politics, Herceptin, medical research, medicine, new drugs, Novartis, pharmaceutical research, pharmaceuticals, research, robots, technology, the future of health care
Comments Off